Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan

JOURNAL OF FOOD AND DRUG ANALYSIS · Published 2025-06-13 · DOI 10.38212/2224-6614.3542

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.38212/2224-6614.3542

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles